Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis
Thiago A.R. Reis, João A. Oliveira‐da‐Silva, Grasiele S.V. Tavares, Débora V.C. Mendonça, Camila S. Freitas, Rafaella R. Costa, Daniela P. Lage, Vívian T. Martins, Amanda S. Machado, Fernanda F. Ramos, Alessandra M. Silva, Fernanda Ludolf, Luciana Maria Ribeiro Antinarelli, Rory Cristiane Fortes de Brito, Miguel Á. Chávez‐Fumagalli, María Victoria Humbert, Bruno Mendes Roatt, Elaine Soares Coimbra, Eduardo Antônio Ferraz Coelho
Topics & Concepts
Leishmania infantumMiltefosineVisceral leishmaniasisIn vivoLeishmaniasisBiologyLeishmaniaPharmacologyAmastigoteParasite loadAmphotericin BIC50DrugIn vitroParasite hostingMicrobiologyImmunologyImmune systemBiochemistryBiotechnologyAntifungalComputer scienceWorld Wide WebResearch on Leishmaniasis StudiesTrypanosoma species research and implicationsParasites and Host Interactions